{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:14:32Z","timestamp":1790252072405,"version":"4.1.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Manipal Academy of Higher Education, Manipal"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Keratitis an inflammatory disorder of the corneal tissue, poses a significant threat to vision and, if left untreated, can even progress to irreversible blindness. Clinical manifestations of the disease include ocular redness, pain, photophobia, excessive tearing, and visual disturbances, with severe cases often leading to corneal ulceration, scarring, or perforation. The global prevalence of keratitis exhibits substantial geographical variability, largely influenced by access to healthcare, environmental factors, and behavioral risk determinants, most notably, the use of contact lenses. In recent years, microbial keratitis (MK) has shown a concerning rise in incidence, particularly among contact lens users, frequently attributed to improper lens hygiene and extended wear. Current therapy mainly depends on the intensive use of topical antimicrobial agents; however, the emergence of multidrug-resistant (MDR) pathogens and the protective nature of biofilms significantly compromise therapeutic efficacy and efficiency. These limitations pave the way to the urgent need for alternative strategies. Bacteriophage therapy, which was in use even before the development of antibiotics, regained interest as a precision-based antibacterial treatment that is capable of selectively targeting pathogenic bacteria, including MDR strains, without disrupting the native ocular microbiota or damaging host tissue. This review explores the different types of keratitis and pathogenesis, highlights the problems related to conventional therapies, and emphasizes the potential of phage therapy as a novel, adjunctive, or standalone intervention.<\/jats:p>","DOI":"10.1007\/s00417-025-06961-z","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T07:59:55Z","timestamp":1758182395000},"page":"3287-3299","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Microbial keratitis in the age of resistance: unlocking the therapeutic potential of phage therapy"],"prefix":"10.1007","volume":"263","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6862-1944","authenticated-orcid":false,"given":"Rafwana","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pritam","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7666-3252","authenticated-orcid":false,"given":"Jesil Mathew","family":"Aranjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,18]]},"reference":[{"issue":"3","key":"6961_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.survophthal.2018.12.003","volume":"64","author":"L Ung","year":"2019","unstructured":"Ung L, Bispo PJM, Shanbhag SS, Gilmore MS, Chodosh J (2019) The persistent dilemma of microbial keratitis: global burden, diagnosis, and antimicrobial resistance. Surv Ophthalmol 64(3):255\u2013271","journal-title":"Surv Ophthalmol"},{"key":"6961_CR2","doi-asserted-by":"crossref","unstructured":"Merali FI, Schein OD (2019) Epidemiology of corneal diseases. In: Foundations of corneal disease: past, present and future Nov 1. Springer, pp 307\u201330","DOI":"10.1007\/978-3-030-25335-6_26"},{"key":"6961_CR3","unstructured":"Jedel E (2024) Diversity and cooperation: lessons from studying pseudomonas aeruginosa interactions with the corneal epithelium. University of California, Berkeley,\u2009ProQuest Dissertations & Theses"},{"key":"6961_CR4","doi-asserted-by":"crossref","unstructured":"Waghmare S V, Jeria S (2022) A review of contact lens-related risk factors and complications. Cureus (14):10","DOI":"10.7759\/cureus.30118"},{"issue":"3","key":"6961_CR5","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1080\/08164622.2022.2033604","volume":"105","author":"PB Morgan","year":"2022","unstructured":"Morgan PB, Efron N (2022) Global contact lens prescribing 2000\u20132020. Clin Exp Optom 105(3):298\u2013312","journal-title":"Clin Exp Optom"},{"issue":"1","key":"6961_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/01.ico.0000138839.29823.57","volume":"24","author":"JH Mah-Sadorra","year":"2005","unstructured":"Mah-Sadorra JH, Yavuz SGA, Najjar DM, Laibson PR, Rapuano CJ, Cohen EJ (2005) Trends in contact lens\u2013related corneal ulcers. Cornea 24(1):51\u201358","journal-title":"Cornea"},{"issue":"2","key":"6961_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/09286580601001347","volume":"14","author":"MJ Bharathi","year":"2007","unstructured":"Bharathi MJ, Ramakrishnan R, Meenakshi R, Padmavathy S, Shivakumar C, Srinivasan M (2007) Microbial keratitis in South India: influence of risk factors, climate, and geographical variation. Ophthalmic Epidemiol 14(2):61\u201369","journal-title":"Ophthalmic Epidemiol"},{"key":"6961_CR8","unstructured":"Koirala K (2021) Epidemiology of persistent febrile illnesses in Eastern Nepal. Theses: Univ Geneve, no Sc Biomed - S Glob 14"},{"issue":"4","key":"6961_CR9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/09286586.2021.1962919","volume":"29","author":"I McCormick","year":"2022","unstructured":"McCormick I, James C, Welton NJ, Mayaud P, Turner KME, Gottlieb SL, Foster A, Looker KJ (2022) Incidence of herpes simplex virus keratitis and other ocular disease: global review and estimates. Ophthalmic Epidemiol 29(4):353\u2013362","journal-title":"Ophthalmic Epidemiol"},{"issue":"3","key":"6961_CR10","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3390\/pathogens12030413","volume":"12","author":"JR Daley","year":"2023","unstructured":"Daley JR, Lee MK, Wang X, Ly M, Samarawickrama C (2023) Epidemiology and economic cost analysis of microbial keratitis from a tertiary referral hospital in Australia. Pathogens 12(3):413","journal-title":"Pathogens"},{"key":"6961_CR11","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ajo.2020.07.026","volume":"220","author":"YY Koh","year":"2020","unstructured":"Koh YY, Sun CC, Hsiao CH (2020) Epidemiology and the estimated burden of microbial keratitis on the health care system in Taiwan: a 14-year population-based study. Am J Ophthalmol 220:152\u2013159","journal-title":"Am J Ophthalmol"},{"key":"6961_CR12","doi-asserted-by":"crossref","unstructured":"Dumitrache M (2024) Ophthalmological pathology and management in eye disease: cornea. In: Clinical ophthalmology: a guide to diagnosis and treatment. Springer, pp 139\u201397","DOI":"10.1007\/978-3-031-68453-1_7"},{"issue":"2","key":"6961_CR13","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ophtha.2016.10.001","volume":"124","author":"C Reynaud","year":"2017","unstructured":"Reynaud C, Rousseau A, Kaswin G, M\u2019garrech M, Barreau E, Labetoulle M (2017) Persistent impairment of quality of life in patients with herpes simplex keratitis. Ophthalmology 124(2):160\u2013169","journal-title":"Ophthalmology"},{"issue":"1","key":"6961_CR14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ophtha.2005.08.013","volume":"113","author":"L Keay","year":"2006","unstructured":"Keay L, Edwards K, Naduvilath T, Taylor HR, Snibson GR, Forde K, Stapleton F (2006) Microbial keratitis: predisposing factors and morbidity. Ophthalmology 113(1):109\u2013116","journal-title":"Ophthalmology"},{"issue":"11","key":"6961_CR15","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1016\/j.ophtha.2017.05.012","volume":"124","author":"A Austin","year":"2017","unstructured":"Austin A, Lietman T, Rose-Nussbaumer J (2017) Update on the management of infectious keratitis. Ophthalmology 124(11):1678\u20131689","journal-title":"Ophthalmology"},{"key":"6961_CR16","doi-asserted-by":"crossref","unstructured":"Herretes S, Wang X, Reyes JMG (2014) Topical corticosteroids as adjunctive therapy for bacterial keratitis. Cochrane Database Syst Rev (10)","DOI":"10.1002\/14651858.CD005430.pub3"},{"key":"6961_CR17","doi-asserted-by":"crossref","unstructured":"Ahmad S, Ahmad S, Qais FA, Khan MS, Ahmad I. Emergence and spread of multidrug resistance in ocular bacterial pathogens: a current update. In: Antibacterial drug discovery to combat MDR: natural compounds, nanotechnology and novel synthetic sources, pp (71\u201393)","DOI":"10.1007\/978-981-13-9871-1_3"},{"issue":"10","key":"6961_CR18","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1080\/23744235.2024.2379492","volume":"56","author":"N Pal","year":"2024","unstructured":"Pal N, Sharma P, Kumawat M, Singh S, Verma V, Tiwari RR, Sarma DK, Nagpal R, Kumar M (2024) Phage therapy: an alternative treatment modality for MDR bacterial infections. Infect Dis 56(10):785\u2013817","journal-title":"Infect Dis"},{"issue":"12","key":"6961_CR19","doi-asserted-by":"publisher","first-page":"4348","DOI":"10.1016\/j.apsb.2022.05.007","volume":"12","author":"H Ling","year":"2022","unstructured":"Ling H, Lou X, Luo Q, He Z, Sun M, Sun J (2022) Recent advances in bacteriophage-based therapeutics: insight into the post-antibiotic era. Acta Pharm Sin B 12(12):4348\u20134364","journal-title":"Acta Pharm Sin B"},{"issue":"7","key":"6961_CR20","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3390\/v10070351","volume":"10","author":"F Oechslin","year":"2018","unstructured":"Oechslin F (2018) Resistance development to bacteriophages occurring during bacteriophage therapy. Viruses 10(7):351","journal-title":"Viruses"},{"issue":"3","key":"6961_CR21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/antibiotics8030131","volume":"8","author":"S Divya Ganeshan","year":"2019","unstructured":"Divya Ganeshan S, Hosseinidoust Z (2019) Phage therapy with a focus on the human microbiota. Antibiotics 8(3):131","journal-title":"Antibiotics"},{"issue":"5","key":"6961_CR22","doi-asserted-by":"publisher","first-page":"868","DOI":"10.3390\/antibiotics12050868","volume":"12","author":"C Airola","year":"2023","unstructured":"Airola C, Severino A, Porcari S, Fusco W, Mullish BH, Gasbarrini A, Cammarota G, Ponziani FR, Ianiro G (2023) Future modulation of gut microbiota: from eubiotics to FMT, engineered bacteria, and phage therapy. Antibiotics 12(5):868","journal-title":"Antibiotics"},{"key":"6961_CR23","doi-asserted-by":"publisher","first-page":"1250257","DOI":"10.3389\/fcimb.2023.1250257","volume":"13","author":"S Shah","year":"2023","unstructured":"Shah S, Wozniak RAF (2023) Staphylococcus aureus and Pseudomonas aeruginosa infectious keratitis: key bacterial mechanisms that mediate pathogenesis and emerging therapeutics. Front Cell Infect Microbiol 13:1250257","journal-title":"Front Cell Infect Microbiol"},{"issue":"17","key":"6961_CR24","doi-asserted-by":"publisher","first-page":"5332","DOI":"10.1128\/AEM.01166-16","volume":"82","author":"T Furusawa","year":"2016","unstructured":"Furusawa T, Iwano H, Hiyashimizu Y, Matsubara K, Higuchi H, Nagahata H, Niwa H, Katayama Y, Kinoshita Y, Hagiwara K, Iwasaki T, Tanji Y, Yokota H, Tamura Y (2016) Phage therapy is effective in a mouse model of bacterial equine keratitis. Appl Environ Microbiol 82(17):5332\u20135339","journal-title":"Appl Environ Microbiol"},{"key":"6961_CR25","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1023\/A:1016716606135","volume":"37","author":"VN Krylov","year":"2001","unstructured":"Krylov VN (2001) Phage therapy in terms of bacteriophage genetics: hopes, prospects, safety, limitations. Russ J Genet 37:715\u2013730","journal-title":"Russ J Genet"},{"issue":"3","key":"6961_CR26","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/ICL.0000000000000884","volume":"48","author":"F Stapleton","year":"2022","unstructured":"Stapleton F, Shrestha GS, Vijay AK, Carnt N (2022) Epidemiology, microbiology, and genetics of contact lens\u2013related and non\u2013contact lens-related infectious keratitis. Eye Contact Lens 48(3):127\u201333","journal-title":"Eye Contact Lens"},{"issue":"5","key":"6961_CR27","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1034\/j.1600-0420.2001.790510.x","volume":"79","author":"I Dejaco-Ruhswurm","year":"2001","unstructured":"Dejaco-Ruhswurm I, Scholz U, Hanselmayer G, Skorpik C (2001) Contact lens induced keratitis associated with contact lens wear. Acta Ophthalmol Scand 79(5):479\u2013483","journal-title":"Acta Ophthalmol Scand"},{"issue":"40","key":"6961_CR28","first-page":"669","volume":"119","author":"P Maier","year":"2022","unstructured":"Maier P, Betancor PK, Reinhard T (2022) Contact lens\u2013associated keratitis\u2014an often underestimated risk. Dtsch Arztebl Int 119(40):669","journal-title":"Dtsch Arztebl Int"},{"issue":"2","key":"6961_CR29","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/ICL.0b013e3181d20cae","volume":"36","author":"LB Szczotka-Flynn","year":"2010","unstructured":"Szczotka-Flynn LB, Pearlman E, Ghannoum M (2010) Microbial contamination of contact lenses, lens care solutions, and their accessories: a literature review. Eye Contact Lens 36(2):116\u2013129","journal-title":"Eye Contact Lens"},{"issue":"7","key":"6961_CR30","doi-asserted-by":"publisher","first-page":"3866","DOI":"10.1128\/IAI.71.7.3866-3874.2003","volume":"71","author":"SMJ Fleiszig","year":"2003","unstructured":"Fleiszig SMJ, Kwong MSF, Evans DJ (2003) Modification of Pseudomonas aeruginosa interactions with corneal epithelial cells by human tear fluid. Infect Immun 71(7):3866\u20133874","journal-title":"Infect Immun"},{"issue":"4","key":"6961_CR31","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/OPX.0b013e3180439c3e","volume":"84","author":"MDP Willcox","year":"2007","unstructured":"Willcox MDP (2007) Pseudomonas aeruginosa infection and inflammation during contact lens wear: a review. Optom Vis Sci 84(4):273\u2013278","journal-title":"Optom Vis Sci"},{"issue":"5","key":"6961_CR32","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/ceo.14113","volume":"50","author":"M Cabrera-Aguas","year":"2022","unstructured":"Cabrera-Aguas M, Khoo P, Watson SL (2022) Infectious keratitis: a review. Clin Exp Ophthalmol 50(5):543\u2013562","journal-title":"Clin Exp Ophthalmol"},{"key":"6961_CR33","doi-asserted-by":"publisher","first-page":"110","DOI":"10.2174\/1874364101206010110","volume":"6","author":"E Karsten","year":"2012","unstructured":"Karsten E, Watson SL, Foster LJR (2012) Diversity of microbial species implicated in keratitis: a review. Open Ophthalmol J 6:110","journal-title":"Open Ophthalmol J"},{"key":"6961_CR34","doi-asserted-by":"publisher","first-page":"104206","DOI":"10.1016\/j.micpath.2020.104206","volume":"145","author":"KG Deepthi","year":"2020","unstructured":"Deepthi KG, Prabagaran SR (2020) Ocular bacterial infections: pathogenesis and diagnosis. Microb Pathog 145:104206","journal-title":"Microb Pathog"},{"key":"6961_CR35","doi-asserted-by":"crossref","unstructured":"Miller D, Cavuoto KM, Alfonso EC (2021) Bacterial keratitis. Infect Cornea Conjunctiva pp 85\u2013104","DOI":"10.1007\/978-981-15-8811-2_6"},{"key":"6961_CR36","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.micpath.2016.12.013","volume":"104","author":"S Lakhundi","year":"2017","unstructured":"Lakhundi S, Siddiqui R, Khan NA (2017) Pathogenesis of microbial keratitis. Microb Pathog 104:97\u2013109","journal-title":"Microb Pathog"},{"issue":"5","key":"6961_CR37","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1080\/08820538.2024.2309533","volume":"35","author":"A Venugopal","year":"2024","unstructured":"Venugopal A, Christy J, Raut V, Preethi P, Patwardhan V, Veeramma V, Madkaikar A, Mangala P, Meenakshi R, Ramakrishnan R (2024) Viral keratitis, surgical intervention in viral keratitis, challenges in diagnosis and treatment of viral keratitis, HSV HZV. Semin Ophthalmol 39(5):340\u201352","journal-title":"Semin Ophthalmol"},{"key":"6961_CR38","doi-asserted-by":"crossref","unstructured":"Liesegang TJ (2016) Ocular viral infections. In: Lennette\u2019s Laboratory diagnosis of viral infections, Apr 19. CRC Press, pp 425\u201348","DOI":"10.3109\/9781420084962.025"},{"issue":"4","key":"6961_CR39","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.preteyeres.2006.05.001","volume":"25","author":"S Kaye","year":"2006","unstructured":"Kaye S, Choudhary A (2006) Herpes simplex keratitis. Prog Retin Eye Res 25(4):355\u2013380","journal-title":"Prog Retin Eye Res"},{"issue":"11","key":"6961_CR40","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.3390\/microorganisms10112224","volume":"10","author":"F Petrillo","year":"2022","unstructured":"Petrillo F, Petrillo A, Sasso FP, Schettino A, Maione A, Galdiero M (2022) Viral infection and antiviral treatments in ocular pathologies. Microorganisms 10(11):2224","journal-title":"Microorganisms"},{"key":"6961_CR41","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jtos.2021.12.001","volume":"24","author":"N Sharma","year":"2022","unstructured":"Sharma N, Bagga B, Singhal D, Nagpal R, Kate A, Saluja G, Maharana PK (2022) Fungal keratitis: a review of clinical presentations, treatment strategies and outcomes. Ocul Surf 24:22\u201330","journal-title":"Ocul Surf"},{"key":"6961_CR42","doi-asserted-by":"publisher","first-page":"103802","DOI":"10.1016\/j.micpath.2019.103802","volume":"138","author":"L Niu","year":"2020","unstructured":"Niu L, Liu X, Ma Z, Yin Y, Sun L, Yang L, Zheng Y (2020) Fungal keratitis: Pathogenesis, diagnosis and prevention. Microb Pathog 138:103802","journal-title":"Microb Pathog"},{"issue":"3","key":"6961_CR43","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3390\/pathogens10030323","volume":"10","author":"N Fanselow","year":"2021","unstructured":"Fanselow N, Sirajuddin N, Yin XT, Huang AJW, Stuart PM (2021) Acanthamoeba keratitis, pathology, diagnosis and treatment. Pathogens 10(3):323","journal-title":"Pathogens"},{"issue":"1","key":"6961_CR44","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/opo.12752","volume":"41","author":"AG de Lacerda","year":"2021","unstructured":"de Lacerda AG, Lira M (2021) Acanthamoeba keratitis: a review of biology, pathophysiology and epidemiology. Ophthalmic Physiol Opt 41(1):116\u2013135","journal-title":"Ophthalmic Physiol Opt"},{"issue":"1","key":"6961_CR45","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ajo.2007.08.040","volume":"145","author":"N Lim","year":"2008","unstructured":"Lim N, Goh D, Bunce C, Xing W, Fraenkel G, Poole TRG, Ficker L (2008) Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis. Am J Ophthalmol 145(1):130\u2013135","journal-title":"Am J Ophthalmol"},{"key":"6961_CR46","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1023\/A:1017939725776","volume":"21","author":"S Sharma","year":"2001","unstructured":"Sharma S (2001) Keratitis. Biosci Rep 21:419\u2013444","journal-title":"Biosci Rep"},{"key":"6961_CR47","doi-asserted-by":"crossref","unstructured":"Brenner J, Chanbour W, Melki SA (2024) Non-infectious keratitis. In: Refractive surgery atlas: surgical techniques and complications. Cham: Springer Nature Switzerland, pp 91\u20139","DOI":"10.1007\/978-3-031-60661-8_10"},{"issue":"4","key":"6961_CR48","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/00004397-199803840-00017","volume":"38","author":"CM Knox","year":"1998","unstructured":"Knox CM, Holsclaw DS (1998) Interstitial keratitis. Int Ophthalmol Clin 38(4):183\u2013195","journal-title":"Int Ophthalmol Clin"},{"issue":"6","key":"6961_CR49","doi-asserted-by":"publisher","first-page":"e229","DOI":"10.1016\/j.jfo.2019.04.001","volume":"42","author":"AS Gauthier","year":"2019","unstructured":"Gauthier AS, Noureddine S, Delbosc B (2019) Interstitial keratitis diagnosis and treatment. J Fr Ophtalmol 42(6):e229\u2013e237","journal-title":"J Fr Ophtalmol"},{"issue":"2","key":"6961_CR50","doi-asserted-by":"publisher","first-page":"252","DOI":"10.18502\/jovr.v17i2.10797","volume":"17","author":"K Hassanpour","year":"2022","unstructured":"Hassanpour K, ElSheikh RH, Arabi A, Frank CR, Elhusseiny AM, Eleiwa TK, Arami S, Djalilian AR, Kheirkhah A (2022) Peripheral ulcerative keratitis: a review. J Ophthalmic Vis Res 17(2):252","journal-title":"J Ophthalmic Vis Res"},{"issue":"6","key":"6961_CR51","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.survophthal.2021.02.013","volume":"66","author":"Y Gupta","year":"2021","unstructured":"Gupta Y, Kishore A, Kumari P, Balakrishnan N, Lomi N, Gupta N, Vanathi M, Tandon R (2021) Peripheral ulcerative keratitis. Surv Ophthalmol 66(6):977\u2013998","journal-title":"Surv Ophthalmol"},{"key":"6961_CR52","doi-asserted-by":"crossref","unstructured":"Robles-Contreras A, Perez-Cano HJ, Babayan-Sosa A, Baca-Lozada O (2013) Bacterial keratitis infection: a battle between virulence factors and the immune response. In: Common eye infections. IntechOpen","DOI":"10.5772\/52264"},{"issue":"4","key":"6961_CR53","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1023\/A:1017991709846","volume":"21","author":"MDP Willcox","year":"2001","unstructured":"Willcox MDP, Holden BA (2001) Contact lens related corneal infections. Biosci Rep 21(4):445\u2013461","journal-title":"Biosci Rep"},{"issue":"1","key":"6961_CR54","first-page":"5","volume":"51","author":"VB Agrawal","year":"2003","unstructured":"Agrawal VB, Tsai RJF (2003) Corneal epithelial wound healing. Indian J Ophthalmol 51(1):5\u201315","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"6961_CR55","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3390\/pathogens4010111","volume":"4","author":"PJM Bispo","year":"2015","unstructured":"Bispo PJM, Haas W, Gilmore MS (2015) Biofilms in infections of the eye. Pathogens 4(1):111\u2013136","journal-title":"Pathogens"},{"key":"6961_CR56","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.3389\/fmicb.2017.02433","volume":"8","author":"J Josse","year":"2017","unstructured":"Josse J, Laurent F, Diot A (2017) Staphylococcal adhesion and host cell invasion: fibronectin-binding and other mechanisms. Front Microbiol 8:2433","journal-title":"Front Microbiol"},{"issue":"4","key":"6961_CR57","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1167\/iovs.05-0956","volume":"47","author":"XY Fu-Shin","year":"2006","unstructured":"Fu-Shin XY, Hazlett LD (2006) Toll-like receptors and the eye. Investig Ophthalmol Vis Sci 47(4):1255\u201363","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"11","key":"6961_CR58","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/eye.2015.118","volume":"29","author":"MA Taube","year":"2015","unstructured":"Taube MA, del Mar Cendra M, Elsahn A, Christodoulides M, Hossain P (2015) Pattern recognition receptors in microbial keratitis. Eye 29(11):1399\u20131415","journal-title":"Eye"},{"key":"6961_CR59","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2174\/1874364101509010049","volume":"9","author":"R Bola\u00f1os-Jim\u00e9nez","year":"2015","unstructured":"Bola\u00f1os-Jim\u00e9nez R, Navas A, L\u00f3pez-Liz\u00e1rraga EP, de Ribot FM, Pe\u00f1a A, Graue-Hern\u00e1ndez EO, Garfias Y (2015) Ocular surface as barrier of innate immunity. Open Ophthalmol J 9:49","journal-title":"Open Ophthalmol J"},{"issue":"23","key":"6961_CR60","doi-asserted-by":"publisher","first-page":"14933","DOI":"10.3390\/ijms232314933","volume":"23","author":"N Fortingo","year":"2022","unstructured":"Fortingo N, Melnyk S, Sutton SH, Watsky MA, Bollag WB (2022) Innate immune system activation, inflammation and corneal wound healing. Int J Mol Sci 23(23):14933","journal-title":"Int J Mol Sci"},{"key":"6961_CR61","doi-asserted-by":"publisher","first-page":"835843","DOI":"10.3389\/fmed.2022.835843","volume":"9","author":"DSJ Ting","year":"2022","unstructured":"Ting DSJ, Mohammed I, Lakshminarayanan R, Beuerman RW, Dua HS (2022) Host defense peptides at the ocular surface: roles in health and major diseases, and therapeutic potentials. Front Med 9:835843","journal-title":"Front Med"},{"key":"6961_CR62","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00441-010-1022-4","volume":"343","author":"L Hazlett","year":"2011","unstructured":"Hazlett L, Wu M (2011) Defensins in innate immunity. Cell Tissue Res 343:175\u2013188","journal-title":"Cell Tissue Res"},{"key":"6961_CR63","doi-asserted-by":"publisher","first-page":"857735","DOI":"10.3389\/fmicb.2022.857735","volume":"13","author":"AH Shannon","year":"2022","unstructured":"Shannon AH, Adelman SA, Hisey EA, Potnis SS, Rozo V, Yung MW, Li JY, Murphy CJ, Thomasy SM, Leonard BC (2022) Antimicrobial peptide expression at the ocular surface and their therapeutic use in the treatment of microbial keratitis. Front Microbiol 13:857735","journal-title":"Front Microbiol"},{"issue":"6","key":"6961_CR64","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1167\/iovs.08-3104","volume":"50","author":"H Zhang","year":"2009","unstructured":"Zhang H, Chen H, Niu J, Wang Y, Xie L (2009) Role of adaptive immunity in the pathogenesis of Candida albicans keratitis. Invest Ophthalmol Vis Sci 50(6):2653\u20132659","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"6961_CR65","first-page":"E-b","volume":"24","author":"JB Ciralsky","year":"2021","unstructured":"Ciralsky JB, Lai E, Bouchard CS (2021) A matrix of pathologic responses in the cornea. Cornea 24:E-b","journal-title":"Cornea"},{"issue":"1","key":"6961_CR66","first-page":"69","volume":"13","author":"M Azeem","year":"2019","unstructured":"Azeem M (2019) Difficulties and challenges in controlling microbial keratitis. Ann Punjab Med Coll 13(1):69\u201371","journal-title":"Ann Punjab Med Coll"},{"issue":"4","key":"6961_CR67","doi-asserted-by":"publisher","first-page":"e32554","DOI":"10.5812\/pedinfect.32554","volume":"3","author":"S Armin","year":"2015","unstructured":"Armin S, Karimi A, Fallah F, Tabatabaii SR, Alfatemi SMH, Khiabanirad P, Shiva F, Fahimzad A, Rahbar M, Mansoorghanaii R, Rafiei Tabatabaii S, Hoseini Alfatemi SM, Shirvani F, Abdolghafoorian H, Sajadi Nia RS (2015) Antimicrobial resistance patterns of Acinetobacter baumannii, Pseudomonas aeruginosa and Staphylococcus aureus isolated from patients with nosocomial infections admitted to Tehran hospitals. Arch Pediatr Infect Dis 3(4):e32554","journal-title":"Arch Pediatr Infect Dis"},{"key":"6961_CR68","doi-asserted-by":"crossref","unstructured":"Shivaji S (2024) Antimicrobial resistance in the diseased human eye: fungal keratitis. In: Antimicrobial resistance of the human eye. CRC Press, pp 151\u2013215","DOI":"10.1201\/9781003451105-5"},{"issue":"2","key":"6961_CR69","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1208\/s12249-023-02516-9","volume":"24","author":"S Ahmed","year":"2023","unstructured":"Ahmed S, Amin MM, Sayed S (2023) Ocular drug delivery: a comprehensive review. AAPS PharmSciTech 24(2):66","journal-title":"AAPS PharmSciTech"},{"issue":"11","key":"6961_CR70","doi-asserted-by":"publisher","first-page":"907","DOI":"10.3390\/jof7110907","volume":"7","author":"N Raj","year":"2021","unstructured":"Raj N, Vanathi M, Ahmed NH, Gupta N, Lomi N, Tandon R (2021) Recent perspectives in the management of fungal keratitis. J Fungi 7(11):907","journal-title":"J Fungi"},{"key":"6961_CR71","unstructured":"Wanger A, Chavez V, Huang R, Wahed A, Dasgupta A, Actor JK (2017) Microbiology and molecular diagnosis in pathology: a comprehensive review for board preparation, certification and clinical practice"},{"key":"6961_CR72","doi-asserted-by":"publisher","first-page":"969863","DOI":"10.3389\/fmicb.2022.969863","volume":"13","author":"C Cason","year":"2022","unstructured":"Cason C, D\u2019Accolti M, Soffritti I, Mazzacane S, Comar M, Caselli E (2022) Next-generation sequencing and PCR technologies in monitoring the hospital microbiome and its drug resistance. Front Microbiol 13:969863","journal-title":"Front Microbiol"},{"issue":"7","key":"6961_CR73","doi-asserted-by":"publisher","first-page":"e0000811","DOI":"10.1371\/journal.pgph.0000811","volume":"2","author":"AW Bartlow","year":"2022","unstructured":"Bartlow AW, Stromberg ZR, Gleasner CD, Hu B, Davenport KW, Jakhar S, Li PE, Vosburg M, Garimella M, Chain PSG, Erkkila TH, Fair JM, Mukundan H (2022) Comparing variability in diagnosis of upper respiratory tract infections in patients using syndromic, next generation sequencing, and PCR-based methods. PLoS Glob Public Health 2(7):e0000811","journal-title":"PLoS Glob Public Health"},{"key":"6961_CR74","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2165\/00002018-200225040-00002","volume":"25","author":"BI Gaynes","year":"2002","unstructured":"Gaynes BI, Fiscella R (2002) Topical nonsteroidal anti-inflammatory drugs for ophthalmic use: a safety review. Drug Saf 25:233\u2013250","journal-title":"Drug Saf"},{"issue":"4","key":"6961_CR75","doi-asserted-by":"publisher","first-page":"396","DOI":"10.4103\/tjosr.tjosr_116_23","volume":"61","author":"M Mohan","year":"2023","unstructured":"Mohan M, Natarajan R, Kaur K, Gurnani B (2023) Treatment approach to corneal ulcer. TNOA J Ophthalmic Sci Res 61(4):396\u2013407","journal-title":"TNOA J Ophthalmic Sci Res"},{"issue":"10","key":"6961_CR76","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1097\/01.ico.0000240084.27663.fd","volume":"25","author":"FW Fraunfelder","year":"2006","unstructured":"Fraunfelder FW (2006) Corneal toxicity from topical ocular and systemic medications. Cornea 25(10):1133\u20131138","journal-title":"Cornea"},{"key":"6961_CR77","doi-asserted-by":"crossref","unstructured":"\u015awierczy\u0144ska M, Tronina A, Mrukwa-Kominek E (2023) Peripheral ulcerative keratitis associated with autoimmune diseases. In: Keratitis-current perspectives. IntechOpen","DOI":"10.5772\/intechopen.112140"},{"issue":"6","key":"6961_CR78","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.stem.2018.05.013","volume":"22","author":"JH Stern","year":"2018","unstructured":"Stern JH, Tian Y, Funderburgh J, Pellegrini G, Zhang K, Goldberg JL, Ali RR, Young M, Xie Y, Temple S (2018) Regenerating eye tissues to preserve and restore vision. Cell Stem Cell 22(6):834\u201349","journal-title":"Cell Stem Cell"},{"key":"6961_CR79","doi-asserted-by":"crossref","unstructured":"Bispo PJM, Ung L, Chodosh J, Gilmore MS (2020) The challenge of antibiotic resistance in corneal infection. Found Corneal Dis Past Present Futur 277\u201388","DOI":"10.1007\/978-3-030-25335-6_23"},{"issue":"5","key":"6961_CR80","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.4103\/ijo.IJO_2537_21","volume":"70","author":"P Biswas","year":"2022","unstructured":"Biswas P, Batra S, Gurha N, Maksane N (2022) Emerging antimicrobial resistance and need for antimicrobial stewardship for ocular infections in India: a narrative review. Indian J Ophthalmol 70(5):1513\u20131521","journal-title":"Indian J Ophthalmol"},{"issue":"8","key":"6961_CR81","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3109\/07853890108995959","volume":"33","author":"A Sulakvelidze","year":"2001","unstructured":"Sulakvelidze A, Morris JG (2001) Bacteriophages as therapeutic agents. Ann Med. 33(8):507\u20139","journal-title":"Ann Med."},{"issue":"3","key":"6961_CR82","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3390\/antibiotics9030135","volume":"9","author":"MP Nikolich","year":"2020","unstructured":"Nikolich MP, Filippov AA (2020) Bacteriophage therapy: developments and directions. Antibiotics 9(3):135","journal-title":"Antibiotics"},{"key":"6961_CR83","doi-asserted-by":"crossref","unstructured":"Singh A, Padmesh S, Dwivedi M, Kostova I (2022) How good are bacteriophages as an alternative therapy to mitigate biofilms of nosocomial infections. Infect Drug Resist 503\u201332","DOI":"10.2147\/IDR.S348700"},{"issue":"2","key":"6961_CR84","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3390\/pharmaceutics14020427","volume":"14","author":"S Liu","year":"2022","unstructured":"Liu S, Lu H, Zhang S, Shi Y, Chen Q (2022) Phages against pathogenic bacterial biofilms and biofilm-based infections: a review. Pharmaceutics 14(2):427","journal-title":"Pharmaceutics"},{"issue":"1","key":"6961_CR85","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/pathogens7010009","volume":"7","author":"RJ O\u2019Callaghan","year":"2018","unstructured":"O\u2019Callaghan RJ (2018) The pathogenesis of Staphylococcus aureus eye infections. Pathogens 7(1):9","journal-title":"Pathogens"},{"key":"6961_CR86","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2174\/1874364101509010167","volume":"9","author":"A Fadlallah","year":"2015","unstructured":"Fadlallah A, Chelala E, Legeais JM (2015) Corneal infection therapy with topical bacteriophage administration. Open Ophthalmol J 9:167","journal-title":"Open Ophthalmol J"},{"issue":"1","key":"6961_CR87","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/(SICI)1097-4660(200001)75:1<6::AID-JCTB157>3.0.CO;2-A","volume":"75","author":"T Marks","year":"2000","unstructured":"Marks T, Sharp R (2000) Bacteriophages and biotechnology: a review. J Chem Technol Biotechnol 75(1):6\u201317","journal-title":"J Chem Technol Biotechnol"},{"key":"6961_CR88","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2147\/IDR.S234353","volume":"13","author":"MT Moghadam","year":"2020","unstructured":"Moghadam MT, Amirmozafari N, Shariati A, Hallajzadeh M, Mirkalantari S, Khoshbayan A, Jazi FM (2020) How phages overcome the challenges of drug resistant bacteria in clinical infections. Infect Drug Resist 13:45","journal-title":"Infect Drug Resist"},{"issue":"2","key":"6961_CR89","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1080\/07388551.2019.1674774","volume":"40","author":"F Safari","year":"2020","unstructured":"Safari F, Sharifi M, Farajnia S, Akbari B, Karimi Baba Ahmadi M, Negahdaripour M, Ghasemi Y (2020) The interaction of phages and bacteria: the co-evolutionary arms race. Crit Rev Biotechnol 40(2):119\u2013137","journal-title":"Crit Rev Biotechnol"},{"issue":"8","key":"6961_CR90","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1038\/s41433-020-01360-6","volume":"35","author":"P Hossain","year":"2021","unstructured":"Hossain P (2021) Microbial keratitis\u2014the true costs of a silent pandemic? Eye 35(8):2071\u20132072","journal-title":"Eye"},{"issue":"4","key":"6961_CR91","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/s41433-020-01339-3","volume":"35","author":"DSJ Ting","year":"2021","unstructured":"Ting DSJ, Ho CS, Deshmukh R, Said DG, Dua HS (2021) Infectious keratitis: an update on epidemiology, causative microorganisms, risk factors, and antimicrobial resistance. Eye 35(4):1084\u20131101","journal-title":"Eye"},{"key":"6961_CR92","doi-asserted-by":"crossref","unstructured":"Egrilmez S, Yildirim-Theveny \u015e (2020) Treatment-resistant bacterial keratitis: challenges and solutions. Clin Ophthalmol 287\u201397","DOI":"10.2147\/OPTH.S181997"},{"key":"6961_CR93","doi-asserted-by":"publisher","first-page":"384","DOI":"10.5935\/0004-2749.20230039","volume":"86","author":"J Maticorena-Quevedo","year":"2022","unstructured":"Maticorena-Quevedo J, Pati\u00f1o-Valderrama L, Arellano-Caro K (2022) Use of topical colistin in bacterial keratitis caused by extensively drug-resistant Pseudomonas aeruginosa: a case report. Arq Bras Oftalmol 86:384\u2013387","journal-title":"Arq Bras Oftalmol"},{"key":"6961_CR94","doi-asserted-by":"publisher","first-page":"907314","DOI":"10.3389\/fcimb.2022.907314","volume":"12","author":"L Plumet","year":"2022","unstructured":"Plumet L, Ahmad-Mansour N, Dunyach-Remy C, Kissa K, Sotto A, Lavigne JP, Costechareyre D, Molle V (2022) Bacteriophage therapy for Staphylococcus aureus infections: a review of animal models, treatments, and clinical trials. Front Cell Infect Microbiol 12:907314","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"6961_CR95","doi-asserted-by":"publisher","first-page":"281","DOI":"10.34172\/bi.2021.10","volume":"11","author":"G Rahimzadeh","year":"2020","unstructured":"Rahimzadeh G, Saeedi M, Nokhodchi A, Moosazadeh M, Ghasemi M, Rostamkalaei SS, Mortazavi P, Eghbali M, Pourbakhshian R, Rezai MS, Nemati Hevelaee E (2020) Evaluation of in-situ gel-forming eye drop containing bacteriophage against Pseudomonas aeruginosa keratoconjunctivitis in vivo. Bioimpacts 11(4):281","journal-title":"Bioimpacts"},{"key":"6961_CR96","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jconrel.2025.01.091","volume":"380","author":"F Abdelrahman","year":"2025","unstructured":"Abdelrahman F, Makky S, Teba HE, Agwa MM, Abd Elaziz MM, Awad R, Hassan YY, Abdelsattar AS, Connerton IF, El-Shibiny A (2025) Potential of vB_Pa_ZCPS1 phage embedded in situ gelling formulations as an ocular delivery system to attenuate Pseudomonas aeruginosa keratitis in a rabbit model. J Control Release 380:52\u201370","journal-title":"J Control Release"},{"key":"6961_CR97","doi-asserted-by":"publisher","first-page":"127413","DOI":"10.1016\/j.micres.2023.127413","volume":"273","author":"R Patil","year":"2023","unstructured":"Patil R, Dehari D, Chaudhuri A, Kumar DN, Kumar D, Singh S, Nath G, Agrawal AK (2023) Recent advancements in nanotechnology-based bacteriophage delivery strategies against bacterial ocular infections. Microbiol Res 273:127413","journal-title":"Microbiol Res"},{"issue":"3","key":"6961_CR98","doi-asserted-by":"publisher","first-page":"e02071","DOI":"10.1128\/aac.02071-21","volume":"66","author":"GA Suh","year":"2022","unstructured":"Suh GA, Lodise TP, Tamma PD, Knisely JM, Alexander J, Aslam S, Barton KD, Bizzell E, Totten KMC, Campbell JL et al (2022) Considerations for the use of phage therapy in clinical practice. Antimicrob Agents Chemother 66(3):e02071-21","journal-title":"Antimicrob Agents Chemother"},{"key":"6961_CR99","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.3389\/fmicb.2020.01161","volume":"11","author":"L Bretaudeau","year":"2020","unstructured":"Bretaudeau L, Tremblais K, Aubrit F, Meichenin M, Arnaud I (2020) Good manufacturing practice (GMP) compliance for phage therapy medicinal products. Front Microbiol 11:1161","journal-title":"Front Microbiol"},{"issue":"10","key":"6961_CR100","doi-asserted-by":"publisher","first-page":"e01353","DOI":"10.1128\/aem.01353-24","volume":"90","author":"X Kou","year":"2024","unstructured":"Kou X, Yang X, Zheng R (2024) Challenges and opportunities of phage therapy for Klebsiella pneumoniae infections. Appl Environ Microbiol 90(10):e01353-e1424","journal-title":"Appl Environ Microbiol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-06961-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-025-06961-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-06961-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T16:02:55Z","timestamp":1770652975000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-025-06961-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,18]]},"references-count":100,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["6961"],"URL":"https:\/\/doi.org\/10.1007\/s00417-025-06961-z","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,18]]},"assertion":[{"value":"24 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that there is no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}